UBS Group’s Rigel Pharmaceuticals RIGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Buy |
68,056
+21,341
| +46% | +$400K | ﹤0.01% | 4170 |
|
|
2025
Q1 | $840K | Buy |
46,715
+33,048
| +242% | +$595K | ﹤0.01% | 4322 |
|
|
2024
Q4 | $230K | Buy |
13,667
+4,491
| +49% | +$75.5K | ﹤0.01% | 5178 |
|
|
2024
Q3 | $148K | Buy |
+9,176
| New | +$148K | ﹤0.01% | 4898 |
|
|
2024
Q2 | – | Sell |
-179,164
| Closed | -$265K | – | 8698 |
|
|
2024
Q1 | $265K | Buy |
179,164
+27,801
| +18% | +$41.1K | ﹤0.01% | 4528 |
|
|
2023
Q4 | $219K | Buy |
151,363
+73,191
| +94% | +$106K | ﹤0.01% | 4552 |
|
|
2023
Q3 | $84.4K | Sell |
78,172
-36,041
| -32% | -$38.9K | ﹤0.01% | 4828 |
|
|
2023
Q2 | $147K | Buy |
114,213
+42,162
| +59% | +$54.4K | ﹤0.01% | 4659 |
|
|
2023
Q1 | $95.1K | Buy |
72,051
+49,014
| +213% | +$64.7K | ﹤0.01% | 4874 |
|
|
2022
Q4 | $34.6K | Buy |
+23,037
| New | +$34.6K | ﹤0.01% | 5932 |
|
|
2022
Q3 | – | Sell |
-590,858
| Closed | -$668K | – | 9610 |
|
|
2022
Q2 | $668K | Buy |
590,858
+293,803
| +99% | +$332K | ﹤0.01% | 3158 |
|
|
2022
Q1 | $888K | Sell |
297,055
-123,930
| -29% | -$370K | ﹤0.01% | 3340 |
|
|
2021
Q4 | $1.12M | Buy |
420,985
+405,153
| +2,559% | +$1.07M | ﹤0.01% | 3358 |
|
|
2021
Q3 | $57K | Sell |
15,832
-27,987
| -64% | -$101K | ﹤0.01% | 5140 |
|
|
2021
Q2 | $191K | Sell |
43,819
-270,930
| -86% | -$1.18M | ﹤0.01% | 4364 |
|
|
2021
Q1 | $1.08M | Buy |
+314,749
| New | +$1.08M | ﹤0.01% | 3289 |
|
|
2020
Q3 | – | Sell |
-34,858
| Closed | -$64K | – | 7340 |
|
|
2020
Q2 | $64K | Sell |
34,858
-44,348
| -56% | -$81.4K | ﹤0.01% | 4837 |
|
|
2020
Q1 | $124K | Sell |
79,206
-128,633
| -62% | -$201K | ﹤0.01% | 4247 |
|
|
2019
Q4 | $445K | Buy |
207,839
+88,904
| +75% | +$190K | ﹤0.01% | 3985 |
|
|
2019
Q3 | $222K | Buy |
118,935
+15,443
| +15% | +$28.8K | ﹤0.01% | 4281 |
|
|
2019
Q2 | $270K | Buy |
103,492
+43,807
| +73% | +$114K | ﹤0.01% | 3920 |
|
|
2019
Q1 | $153K | Sell |
59,685
-636,426
| -91% | -$1.63M | ﹤0.01% | 4017 |
|
|
2018
Q4 | $1.6M | Buy |
696,111
+690,511
| +12,331% | +$1.59M | ﹤0.01% | 2619 |
|
|
2018
Q3 | $18K | Sell |
5,600
-12,049
| -68% | -$38.7K | ﹤0.01% | 5951 |
|
|
2018
Q2 | $50K | Sell |
17,649
-405,765
| -96% | -$1.15M | ﹤0.01% | 5064 |
|
|
2018
Q1 | $1.5M | Buy |
423,414
+218,868
| +107% | +$775K | ﹤0.01% | 2736 |
|
|
2017
Q4 | $794K | Buy |
204,546
+193,426
| +1,739% | +$751K | ﹤0.01% | 3162 |
|
|
2017
Q3 | $28K | Sell |
11,120
-90,332
| -89% | -$227K | ﹤0.01% | 5315 |
|
|
2017
Q2 | $277K | Buy |
101,452
+95,397
| +1,576% | +$260K | ﹤0.01% | 3713 |
|
|
2017
Q1 | $20K | Sell |
6,055
-1,362
| -18% | -$4.5K | ﹤0.01% | 5227 |
|
|
2016
Q4 | $17K | Buy |
7,417
+1,417
| +24% | +$3.25K | ﹤0.01% | 5665 |
|
|
2016
Q3 | $22K | Buy |
6,000
+5,696
| +1,874% | +$20.9K | ﹤0.01% | 5336 |
|
|
2016
Q2 | $1K | Buy |
+304
| New | +$1K | ﹤0.01% | 6640 |
|
|
2015
Q4 | – | Sell |
-3,433
| Closed | -$8K | – | 6983 |
|
|
2015
Q3 | $8K | Buy |
+3,433
| New | +$8K | ﹤0.01% | 6046 |
|